Cargando…

COVID-19-induced latent relapsing hypercoagulable state in the absence of persistent viral infection

Hypercoagulability in coronavirus disease 2019 infection is already a known fact. But in this article, we have discussed a unique case where the patient had suffered from relapsing thrombus formation. This report describes the case of a patient who presented with chronic coronavirus disease 2019-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajra, Adrija, Torrado, Juan, Alviar, Carlos L, Bangalore, Sripal, Keller, Norma, Faillace, Robert, Sokol, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310331/
https://www.ncbi.nlm.nih.gov/pubmed/35899245
http://dx.doi.org/10.1177/2050313X221113934
Descripción
Sumario:Hypercoagulability in coronavirus disease 2019 infection is already a known fact. But in this article, we have discussed a unique case where the patient had suffered from relapsing thrombus formation. This report describes the case of a patient who presented with chronic coronavirus disease 2019-induced recurrent thrombi refractory to multiple antithrombotic regimens because of multiple recurrent inflammatory flares without any evidence of chronic persistent viral infection. The patient was treated with anticoagulation and anti-inflammatory medications. Still, he had repeated episodes of right ventricular thrombus. Coronavirus disease 2019 can provoke a severe relapsing hypercoagulable state without evidence of persisting viral infection. Rebound inflammatory flares rather than viral recurrence may play a trigger.